news roundup

IQVIA Report on the Changing Landscape of R&D

The IQVIA Institute has has released its Clinical Development Productivity Index, which reflects changes in trial complexity, success and duration. In a report, using the Index, it examined historical and future clinical trial productivity trends across therapy areas.

COPD Drug Development Lags Behind Asthma

GlobalData's latest report says the Chronic Obstructive Pulmonary Disease pipeline is lagging in terms of first-in-class product innovation when it comes to asthma.

PopsiCube Opens Russian Affiliate

CRO PopsiCube has opened a Russian affiliate in Moscow.

Latest Business News and People Moves

Did you miss the latest business milestones and people news last week. Read it here.

Articles

Understanding the Statistical Implications of Undetected Risk

Nonadherence in clinical trials plays a critical role in influencing data quality, trial results and, subsequently trial cost and duration. It is estimated that greater than 20% of patients never take the IMP leading to high rates of trial failure. Nonadherence is endemic across all sponsors and all indications.

A Second Look at Chemotherapy

In this article, Bill Newell, CEO of Sutro Biopharma, discusses the use of a cell-free protein synthesis approach to develop antibody-drug conjugates, bispecific antibodies, and cytokine derivatives to deliver cytotoxic therapies.

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com